Peptidyl-lysine modification

pathway activity — cross-omics
GO:0018205Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine modification pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are SMARCC2, VCAN, and PCOLCE, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine modification activity versus SMARCC2 in LSCC (Pearson r = 0.26).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCSMARCC2 →+0.143+0.024<.001<.00136
CCRCCVCAN →+0.768+0.020<.001<.00136
CCRCCPCOLCE →+0.692+0.021<.001<.00136
PDACANO10 →-0.376-0.018.002.00236
HNSCRCOR3 →+0.355+0.055<.001<.00135
HNSCS100A9 →-1.027-0.065<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018205 vs SMARCC2 — LSCC

Per-sample scatter of Peptidyl-lysine modification activity vs SMARCC2 in LSCC.

Explore this scatter interactively →

Exploration